Literature DB >> 10695079

Redox imbalance in the critically ill.

J M Gutteridge1, J Mitchell.   

Abstract

The majority of deaths amongst critically ill patients requiring intensive care are attributable to sepsis and its sequelae: septic shock, the systemic inflammatory response syndrome (SIRS) and the acute respiratory distress syndrome (ARDS). Clinically, sepsis/SIRS and ARDS are characterised by disordered vascular control, manifest as systemic hypotension and peripheral vasodilation refractory to intravascular volume resuscitation and vasopressor therapy; and pulmonary hypertension. Experimental and clinical evidence demonstrates that these patients suffer from severe oxidative stress. Thus, our own and other groups have shown that the vascular pathology of sepsis/SIRS and ARDS is initiated through the uncontrolled production of reactive oxygen (ROS) and reactive nitrogen species (RNS) which modulate inflammatory cell adhesion and cause direct injury to endothelium (Fig. 1).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10695079     DOI: 10.1258/0007142991902295

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  26 in total

1.  Sulfuretin protects hepatic cells through regulation of ROS levels and autophagic flux.

Authors:  Yu-Ting Lu; Yu-Feng Xiao; Yu-Feng Li; Jia Li; Fa-Jun Nan; Jing-Ya Li
Journal:  Acta Pharmacol Sin       Date:  2018-12-18       Impact factor: 6.150

2.  Oxidative stress participates in quadriceps muscle dysfunction during the initiation of osteoarthritis in rats.

Authors:  Dur-Zong Hsu; Pei-Yi Chu; Po-Ting Wu; Po-Chuan Shen; I-Ming Jou
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Plasma Phospholipid Fatty Acid Profile is Altered in Both Septic and Non-Septic Critically Ill: A Correlation with Inflammatory Markers and Albumin.

Authors:  František Novak; J Borovska; M Vecka; J Rychlikova; L Vavrova; H Petraskova; A Zak; O Novakova
Journal:  Lipids       Date:  2016-12-30       Impact factor: 1.880

4.  Resveratrol Protects Sepsis-Induced Oxidative DNA Damage in Liver and Kidney of Rats.

Authors:  Sevtap Aydın; Tevfik Tolga Şahin; Merve Bacanlı; Gökçe Taner; Arif Ahmet Başaran; Mehtap Aydın; Nurşen Başaran
Journal:  Balkan Med J       Date:  2016-11-01       Impact factor: 2.021

5.  Cadmium induced MTs synthesis via oxidative stress in yeast Saccharomyces cerevisiae.

Authors:  Jianghai Liu; Yingmei Zhang; Dejun Huang; Gang Song
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

6.  Analysis of the oxidative damage-induced conformational changes of apo- and holocalmodulin by dose-dependent protein oxidative surface mapping.

Authors:  Joshua S Sharp; Kenneth B Tomer
Journal:  Biophys J       Date:  2006-12-08       Impact factor: 4.033

7.  The investigation of immunomodulatory activities of Gloeostereum incaratum polysaccharides in cyclophosphamide-induced immunosuppression mice.

Authors:  Di Wang; Qian Li; Yidi Qu; Mengya Wang; Lanzhou Li; Yang Liu; Yu Li
Journal:  Exp Ther Med       Date:  2018-01-30       Impact factor: 2.447

8.  Immuno-spin trapping of a post-translational carboxypeptidase B1 radical formed by a dual role of xanthine oxidase and endothelial nitric oxide synthase in acute septic mice.

Authors:  Saurabh Chatterjee; Marilyn Ehrenshaft; Suchandra Bhattacharjee; Leesa J Deterding; Marcelo G Bonini; Jean Corbett; Maria B Kadiiska; Kenneth B Tomer; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2008-11-07       Impact factor: 7.376

9.  Metabolomics investigation of exercise-modulated changes in metabolism in rat liver after exhaustive and endurance exercises.

Authors:  Chi-Chang Huang; Wan-Teng Lin; Feng-Lin Hsu; Pi-Wen Tsai; Chia-Chung Hou
Journal:  Eur J Appl Physiol       Date:  2009-10-29       Impact factor: 3.078

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.